Genetic Technologies Ltd Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 2 255 975 and sold 352 494 GENE shares in the last 100 trades.

Insider Power

(Last 100 transactions)
0
Buy 2 255 975 Shares
Sell 352 494 Shares

Historical Insider Trades

Date Type Action Person Amount
Feb 10, 2007 Stock Options (right to buy) Buy Patou Gary 928 463
Dec 12, 2005 Stock Options (right to buy) Buy Patou Gary 42 411
Aug 25, 2004 Stock Options Sell Patou Gary 5 500
Aug 24, 2004 Stock Options Sell Patou Gary 2 500
Jul 01, 2004 Stock Options Sell Hennessey Robert J 1 500
Jun 29, 2004 Stock Options(right to buy) Buy Kirby Pamela J 9 047
Jun 29, 2004 Stock Options(right to buy) Buy Kirby Pamela J 25 000
Jun 29, 2004 Buy Kirby Pamela J 0
May 05, 2004 Stock Options (right to buy) Buy Stone David K 184
May 05, 2004 Stock Options (right to buy) Buy Riedel Norbert G 184
Apr 13, 2004 Stock Options Sell Hennessey Robert J 10 947
Apr 13, 2004 Stock Options Sell Hennessey Robert J 25 000
Apr 13, 2004 Stock Options Sell Hennessey Robert J 547
Apr 13, 2004 Stock Options (right to buy Buy Riedel Norbert G 342
Apr 13, 2004 Stock Options (right to buy Buy Riedel Norbert G 20 525
Apr 13, 2004 Stock Options (right to buy Buy Riedel Norbert G 25 000
Apr 13, 2004 Stock Options (right to buy) Buy Riedel Norbert G 547
Apr 13, 2004 Stock Options (right to buy) Buy Stone David K 15 052
Apr 13, 2004 Stock Options (right to buy) Buy Stone David K 25 000
Apr 13, 2004 Stock Options (right to buy) Buy Stone David K 547
Apr 13, 2004 Stock Options (right to buy) Buy Rutter William J 10 947
Apr 13, 2004 Stock Options (right to buy) Buy Rutter William J 10 833
Apr 13, 2004 Stock Options (right to buy) Buy Rutter William J 547
Apr 13, 2004 Stock Option (right to buy) Buy Loucks Vernon R Jr 342
Apr 13, 2004 Stock Option (right to buy) Buy Loucks Vernon R Jr 13 684
Click to get the best stock tips daily for free!

About Genetic Technologies Ltd

Genetic Technologies Ltd Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecol... GENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT